We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PBYI market cap is 357.82M. The company's latest EPS is USD 0.48 and P/E is 14.69.
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.01M | 52.44M | 54.48M | 75.45M | 44.81M |
| Operating Income | 3.98M | 6.64M | 9.57M | 17.11M | -3.83M |
| Net Income | 2.97M | 5.86M | 8.84M | 13.44M | -3.75M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 253.16M | 228.03M | 235.64M | 230.47M | 228.37M |
| Operating Income | 1.29M | 30.72M | 32.64M | 30.97M | 37.3M |
| Net Income | -29.13M | 2k | 21.59M | 30.28M | 31.11M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 196.18M | 194.92M | 202.86M | 216.3M | 192.7M |
| Total Liabilities | 99.07M | 90.2M | 87.59M | 85.96M | 64.28M |
| Total Equity | 97.11M | 104.72M | 115.27M | 130.34M | 128.42M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 226.59M | 222.06M | 230.53M | 213.33M | 216.3M |
| Total Liabilities | 229.03M | 200.45M | 177.09M | 121.21M | 85.96M |
| Total Equity | -2.45M | 21.61M | 53.44M | 92.13M | 130.34M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 3.61M | 14.08M | 9.69M | 14.42M | 15.42M |
| Investing | 1.53M | -11.25M | 506k | -26.98M | 2.47M |
| Financing | -11.33M | -11.2M | -11.33M | -11.33M | -11.33M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 20.65M | -15.83M | 27.01M | 38.92M | 41.8M |
| Investing | -10.88M | 7.1M | -19.13M | -20.44M | -36.19M |
| Financing | -31.93M | 12.22M | N/A | -33.85M | -45.2M |
| Market Cap | 357.823M |
| Price to Earnings Ratio | 14.69 |
| Price to Sales Ratio | 1.58 |
| Price to Cash Ratio | 0.71 |
| Price to Book Ratio | 2.79 |
| Dividend Yield (LTM) | N/A |
| Shares Outstanding | 50.9M |
| Average Volume (1 week) | 226.82k |
| Average Volume (1 Month) | 226.69k |
| 52 Week Change | 87.97% |
| 52 Week High | 7.87 |
| 52 Week Low | 3.03 |
| Spread (Intraday) | 0.6 (8.22%) |
| Company Name | Puma Biotechnology Inc |
| Address |
10880 Wilshire Boulevard Los Angeles, California 90024 |
| Website | https://www.pumabiotechnology.com |
| Industry | Biotechnology & Life Sciences |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Register with Email
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.
Hot Features
Premium
